LPK-26
Prijeđi na navigaciju
Prijeđi na pretragu
![]() | |||
(IUPAC) ime | |||
---|---|---|---|
2-(3,4-dichlorophenyl)-N-[(2S)-1-(2,5-dihydropyrrol-1-yl)-3-methylbutan-2-yl]-N-methylacetamide | |||
Klinički podaci | |||
Identifikatori | |||
CAS broj | 492451-07-7 | ||
ATC kod | ? | ||
PubChem[1][2] | 10043746 | ||
Hemijski podaci | |||
Formula | C18H24Cl2N2O | ||
Mol. masa | 355.301 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status |
LPK-26 je lek, koji je visoko selektivni κ-opioidni agonist. On je analgetik.[3]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Tao YM, Li QL, Zhang CF, Xu XJ, Chen J, Ju YW, Chi ZQ, Long YQ, Liu JG (April 2008). „LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential”. European Journal of Pharmacology 584 (2-3): 306–11. DOI:10.1016/j.ejphar.2008.02.028. PMID 18353307.